1604585

RivaroxabanRelated Compound H

United States Pharmacopeia (USP) Reference Standard

• 同義詞: (S)-4,5-Dichloro-N-({2-oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidin-5-yl}methyl)thiophene2-carboxamide
• 經驗公式（希爾表示法）: C₁₉H₁₇Cl₂N₃O₅S
• CAS號碼: 1770812-37-7
• 分子量：: 470.33
• MDL號碼: MFCD28347519
• 分類程式碼代碼: 41116107
• NACRES: NA.24

屬性

• API 家族: rivaroxaban
• 包裝: pkg of 20 mg
• 製造商／商標名: USP
• 應用: pharmaceutical (small molecule)
• 形式: neat
• 儲存溫度: 2-8°C
• SMILES 字串: [s]1c(c(cc1C(=O)NC[C@@H]2OC(=O)N(C2)c3ccc(cc3)N4CCOCC4=O)Cl)Cl
• InChI: 1S/C19H17Cl2N3O5S/c20-14-7-15(30-17(14)21)18(26)22-8-13-9-24(19(27)29-13)12-3-1-11(2-4-12)23-5-6-28-10-16(23)25/h1-4,7,13H,5-6,8-10H2,(H,22,26)/t13-/m0/s1
• InChI 密鑰: CCLKYVZRBJQFLK-ZDUSSCGKSA-N

描述

一般說明

This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.

應用

RivaroxabanRelated Compound H USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia.

分析報告

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  

其他說明

Sales restrictions may apply.

安全資訊

• 象形圖: GHS09
• 危險聲明: H411
• 防範說明: P273 - P391 - P501
• 危險分類: Aquatic Chronic 2
• 儲存類別代碼: 11 - Combustible Solids
• 水污染物質分類（WGK）: WGK 3
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable